1. Home
  2. CALC vs FRSX Comparison

CALC vs FRSX Comparison

Compare CALC & FRSX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CALC
  • FRSX
  • Stock Information
  • Founded
  • CALC 2011
  • FRSX N/A
  • Country
  • CALC United States
  • FRSX Israel
  • Employees
  • CALC N/A
  • FRSX N/A
  • Industry
  • CALC Biotechnology: Pharmaceutical Preparations
  • FRSX Computer Software: Prepackaged Software
  • Sector
  • CALC Health Care
  • FRSX Technology
  • Exchange
  • CALC Nasdaq
  • FRSX Nasdaq
  • Market Cap
  • CALC 36.0M
  • FRSX 31.1M
  • IPO Year
  • CALC N/A
  • FRSX 2017
  • Fundamental
  • Price
  • CALC $2.52
  • FRSX $0.89
  • Analyst Decision
  • CALC Strong Buy
  • FRSX
  • Analyst Count
  • CALC 5
  • FRSX 0
  • Target Price
  • CALC $18.20
  • FRSX N/A
  • AVG Volume (30 Days)
  • CALC 31.9K
  • FRSX 221.3K
  • Earning Date
  • CALC 03-27-2025
  • FRSX 03-26-2025
  • Dividend Yield
  • CALC N/A
  • FRSX N/A
  • EPS Growth
  • CALC N/A
  • FRSX N/A
  • EPS
  • CALC N/A
  • FRSX N/A
  • Revenue
  • CALC N/A
  • FRSX $473,000.00
  • Revenue This Year
  • CALC N/A
  • FRSX N/A
  • Revenue Next Year
  • CALC N/A
  • FRSX N/A
  • P/E Ratio
  • CALC N/A
  • FRSX N/A
  • Revenue Growth
  • CALC N/A
  • FRSX 3.28
  • 52 Week Low
  • CALC $2.05
  • FRSX $0.57
  • 52 Week High
  • CALC $6.27
  • FRSX $2.63
  • Technical
  • Relative Strength Index (RSI)
  • CALC 37.60
  • FRSX 37.36
  • Support Level
  • CALC $2.59
  • FRSX $0.95
  • Resistance Level
  • CALC $2.75
  • FRSX $1.04
  • Average True Range (ATR)
  • CALC 0.23
  • FRSX 0.10
  • MACD
  • CALC 0.00
  • FRSX -0.03
  • Stochastic Oscillator
  • CALC 27.55
  • FRSX 2.19

About CALC CalciMedica Inc.

CalciMedica Inc is a clinical-stage biopharmaceutical company focused on developing therapies for life-threatening inflammatory diseases with high unmet need. Its proprietary technology targets the inhibition of calcium release-activated calcium channels designed to modulate the immune response and protect against tissue cell injury, with the potential to provide therapeutic benefits in life-threatening inflammatory diseases for which there are no approved therapies.

About FRSX Foresight Autonomous Holdings Ltd.

Foresight Autonomous Holdings Ltd is a technology company engaged in the design, development and commercialization of vision systems for the automotive industry. The company develops both in-line-of-sight vision systems and beyond-line-of-sight cellular-based applications through its wholly-owned subsidiaries. Its systems are designed to improve driving safety by enabling highly accurate and reliable threat detection while ensuring the lowest rates of false alerts. Foresight is pursuing several markets and believes its advanced systems will revolutionize automotive safety by providing an automotive-grade, cost-effective platform.

Share on Social Networks: